CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy
Identifieur interne : 003D56 ( Istex/Checkpoint ); précédent : 003D55; suivant : 003D57CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy
Auteurs : V. Planté-Bordeneuve [Royaume-Uni] ; O. Bandmann [Royaume-Uni] ; G. Wenning [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; Harding [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 1995-05.
English descriptors
Abstract
Molecular genetic studies of the cytochrome P450 system enzyme CYP2D6, which hydroxylates debrisoquine, have indicated an excess of mutant alleles in large series of patients with Parkinosn's disease (PD) when compared with controls. We have investigated CYP2D6 polymorphism in 91 patients with multiple system atrophy (MSA) in order to determine if this finding is specific to PD or if there is similar evidence of genetic susceptibility to neurotoxicity in MSA. The distribution of CYP2D6 alleles was not significantly different between MSA patients and controls, and there were fewer poor metabolisers in the MSA group than in the control group.
Url:
DOI: 10.1002/mds.870100307
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:A74D2BAFCD624AC24D50C184996E977E8D1C8BCALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy</title>
<author><name sortKey="Plante Ordeneuve, V" sort="Plante Ordeneuve, V" uniqKey="Plante Ordeneuve V" first="V." last="Planté-Bordeneuve">V. Planté-Bordeneuve</name>
</author>
<author><name sortKey="Bandmann, O" sort="Bandmann, O" uniqKey="Bandmann O" first="O." last="Bandmann">O. Bandmann</name>
</author>
<author><name sortKey="Wenning, G" sort="Wenning, G" uniqKey="Wenning G" first="G." last="Wenning">G. Wenning</name>
</author>
<author><name sortKey="Quinn, N P" sort="Quinn, N P" uniqKey="Quinn N" first="N. P." last="Quinn">N. P. Quinn</name>
</author>
<author><name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name>
</author>
<author><name sortKey="Harding" sort="Harding" uniqKey="Harding" last="Harding">Harding</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A74D2BAFCD624AC24D50C184996E977E8D1C8BCA</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1002/mds.870100307</idno>
<idno type="url">https://api.istex.fr/document/A74D2BAFCD624AC24D50C184996E977E8D1C8BCA/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003989</idno>
<idno type="wicri:Area/Istex/Curation">003989</idno>
<idno type="wicri:Area/Istex/Checkpoint">003D56</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy</title>
<author><name sortKey="Plante Ordeneuve, V" sort="Plante Ordeneuve, V" uniqKey="Plante Ordeneuve V" first="V." last="Planté-Bordeneuve">V. Planté-Bordeneuve</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Bandmann, O" sort="Bandmann, O" uniqKey="Bandmann O" first="O." last="Bandmann">O. Bandmann</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Wenning, G" sort="Wenning, G" uniqKey="Wenning G" first="G." last="Wenning">G. Wenning</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Quinn, N P" sort="Quinn, N P" uniqKey="Quinn N" first="N. P." last="Quinn">N. P. Quinn</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Harding" sort="Harding" uniqKey="Harding" last="Harding">Harding</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University Department of Clinical Neurology (Neurogenetics and Movement Disorders Sections and Parkinson's Disease Society Brain Bank), Institute of Neurology, London</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1995-05">1995-05</date>
<biblScope unit="vol">10</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="277">277</biblScope>
<biblScope unit="page" to="278">278</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">A74D2BAFCD624AC24D50C184996E977E8D1C8BCA</idno>
<idno type="DOI">10.1002/mds.870100307</idno>
<idno type="ArticleID">MDS870100307</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cytochrome P450</term>
<term>Multiple system atrophy</term>
<term>Parkinson's disease</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Molecular genetic studies of the cytochrome P450 system enzyme CYP2D6, which hydroxylates debrisoquine, have indicated an excess of mutant alleles in large series of patients with Parkinosn's disease (PD) when compared with controls. We have investigated CYP2D6 polymorphism in 91 patients with multiple system atrophy (MSA) in order to determine if this finding is specific to PD or if there is similar evidence of genetic susceptibility to neurotoxicity in MSA. The distribution of CYP2D6 alleles was not significantly different between MSA patients and controls, and there were fewer poor metabolisers in the MSA group than in the control group.</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
</region>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Plante Ordeneuve, V" sort="Plante Ordeneuve, V" uniqKey="Plante Ordeneuve V" first="V." last="Planté-Bordeneuve">V. Planté-Bordeneuve</name>
</region>
<name sortKey="Bandmann, O" sort="Bandmann, O" uniqKey="Bandmann O" first="O." last="Bandmann">O. Bandmann</name>
<name sortKey="Daniel, S E" sort="Daniel, S E" uniqKey="Daniel S" first="S. E." last="Daniel">S. E. Daniel</name>
<name sortKey="Harding" sort="Harding" uniqKey="Harding" last="Harding">Harding</name>
<name sortKey="Quinn, N P" sort="Quinn, N P" uniqKey="Quinn N" first="N. P." last="Quinn">N. P. Quinn</name>
<name sortKey="Wenning, G" sort="Wenning, G" uniqKey="Wenning G" first="G." last="Wenning">G. Wenning</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D56 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 003D56 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Istex |étape= Checkpoint |type= RBID |clé= ISTEX:A74D2BAFCD624AC24D50C184996E977E8D1C8BCA |texte= CYP2D6‐debrisoquine hydroxylase gene polymorphism in multiple system atrophy }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |